Atlas Trials

Magnesium, Partenium, Andrographis, Co-enzyme Q10 and Riboflavin (PACR) in Migraine Prophylaxis

Clinical trial NCT03190044 · UNKNOWN

Trial details

NCT number
NCT03190044
Sponsor
University of Roma La Sapienza
Status
UNKNOWN
Phase
Not Applicable
Study type
INTERVENTIONAL
Migraine Disorders
Start date
2017-06-06
Primary completion
2019-12-30
Enrollment
82

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.